Significance of ER–Src Axis in Hormonal Therapy Resistance

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-1312-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hormonal Resistance and Metastasis ER-Coregulartor-Src Signaling Targeted Therapy

2011English

Hormonal Therapy With Vigabatrin Is Superior to Hormonal Therapy Alone in Infantile Spasms

Journal of Pediatrics
Child HealthPediatricsPerinatology
2017English

Hormonal Therapy in Uterine Sarcomas

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Correction: ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Cancer Discovery
Oncology
2019English

Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via SRC-Rac1 Signaling Axis

Frontiers in Oncology
Cancer ResearchOncology
2020English

Voice Therapy for Hormonal Dysphonias

Japan Journal of Logopedics and Phoniatrics
LPNLVNSpeechHearing
2005English

A Side-Effect of Masculinizing Hormonal Therapy

British Journal of Dermatology
DermatologyMedicine
2019English

Controversies in the Hormonal Adjuvant Therapy of Postmenopausal Patients

Breast Cancer Research
Cancer ResearchOncology
2009English

The Use of Hormonal Therapy in “Andropause”: The Con Side

Canadian Urological Association Journal
Urology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy